2009
DOI: 10.1016/j.jconrel.2008.12.014
|View full text |Cite
|
Sign up to set email alerts
|

Conjugation of salmon calcitonin to a combed-shaped end functionalized poly(poly(ethylene glycol) methyl ether methacrylate) yields a bioactive stable conjugate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
69
0

Year Published

2011
2011
2014
2014

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 75 publications
(71 citation statements)
references
References 39 publications
2
69
0
Order By: Relevance
“…injection of PBS were without effect on plasma calcium levels. 22 Homeostatic events mean that plasma calcium levels do not move from 2.5 mM in untreated conditions. Figure 8.…”
Section: Characterization Of Sct-polymer Conjugates: Attachment Sitementioning
confidence: 99%
“…injection of PBS were without effect on plasma calcium levels. 22 Homeostatic events mean that plasma calcium levels do not move from 2.5 mM in untreated conditions. Figure 8.…”
Section: Characterization Of Sct-polymer Conjugates: Attachment Sitementioning
confidence: 99%
“…We recently demonstrated specific cysteine-1 conjugation of sCT to a combedshaped end-functionalised poly(PEG-methyl ether methacrylate) comb-shaped polymer, (sCT-P) [11]. The 6.5 kDa MW conjugate had increased proteolytic stability compared to both free sCT and a linear PEG version of similar total MW.…”
Section: Introductionmentioning
confidence: 99%
“…The 6.5 kDa MW conjugate had increased proteolytic stability compared to both free sCT and a linear PEG version of similar total MW. In addition to lengthening the half-life of sCT following injection to rats, in vitro and in vivo efficacy and potency was retained by the conjugate [11]. The aim of the present study was to evaluate the effects of increasing the MW of the comb-shaped polymer conjugated onto sCT on both in vitro bioactivity and in vivo PK following i.v.…”
Section: Introductionmentioning
confidence: 99%
“…[6,17,18] Recently, comb-like PEG polymers, i.e., polyethylene glycol grafted poly(meth)acrylates, have proved to be potent alternatives to linear and branched PEG for improving the pharmacokinetics of protein drugs. [18][19][20] When compared to the linear PEG with equivalent molecular weights, the comb-like PEG displays greater steric hindrance, thus potentially enhancing biostability and lowering clearance rates of the conjugated biotherapeutics.…”
Section: Introductionmentioning
confidence: 99%
“…[6,17,18] Recently, comb-like PEG polymers, i.e., polyethylene glycol grafted poly(meth)acrylates, have proved to be potent alternatives to linear and branched PEG for improving the pharmacokinetics of protein drugs. [18][19][20] When compared to the linear PEG with equivalent molecular weights, the comb-like PEG displays greater steric hindrance, thus potentially enhancing biostability and lowering clearance rates of the conjugated biotherapeutics. Moreover, comb-shaped PEG-(meth)acrylate polymers can be prepared by reversible addition fragmentation chain transfer (RAFT) polymerization [21][22][23][24][25] and atom transfer radical polymerization (ATRP) techniques, [26][27][28][29] which offer facile synthetic routes to the generation of polymers with controlled molecular weight, varying macromolecular architectures and defined endgroup functionalities.…”
Section: Introductionmentioning
confidence: 99%